- Price is above the Trend Line, keeping the weekly tape constructive.
- Activity pressure is positive on the latest completed week.
COLO-B
CPH
Week ended 07 Aug 2026
Weekly Investor Report
Coloplast A/S · Healthcare · Medical Instruments & Supplies
Latest close
437.5 DKK
1.9%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is 0.8% above the Trend Line and sits at 25.5% of its 52-week range. The latest completed week returned 1.9%, after a 9.1% four-week move. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal.
Setup score
37
out of 100
Latest Close
437.5 DKK
7 Aug 2026
1W Return
1.9%
latest completed week
4W Return
9.1%
short-term follow-through
12W Return
11.0%
quarterly tape
Trend Breadth
0.0%
0 of 52 weeks active
Volume Ratio
0.9x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Next-week expectancy is negative at 41.94% based on similar historical setup states.
- Activity pressure is weak, so confirmation is not yet broad enough.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
1.9%
Latest completed week; four-week move 9.1%.
Indicator stack
0/100
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 41.94%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
5 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is 0.8% above the Trend Line and sits at 25.5% of its 52-week range. The latest completed week returned 1.9%, after a 9.1% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.9x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0712-week average 0.02
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure5/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.07Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 9.1% over four weeks, 11.0% over 12 weeks, and -24.0% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year0
Trend breadth0.0%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure1.15Latest activity-pressure read.
Pressure change1247.8%Four-week change in activity pressure.
Leadership-14.88Latest relative-leadership reading.
RS change41.2%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 5 relevant articles.
0 positive · 5 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-29.3%Distance below the 52-week high.
13-week volatility3.1%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher11 of 2615 weeks finished lower.
Best week+6.4%Week of 31 Jul.
Worst week-7.9%Week of 24 Apr.
Latest week+1.9%Week of 7 Aug.
Shape of recent returns
Strong gains3
Modest gains8
Flat weeks0
Modest losses11
Sharp losses4
Recent vol3.1%13-week weekly-return volatility.
Base vol3.4%52-week weekly-return volatility.
Up/down split22/30Count of positive and negative weeks in the 52-week window.
Average skew2.8% / -2.9%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorDK Healthcare
4-week rank5 / 21
Group average4.0%
Trend breadth28.6%
Trend28.6%active weekly trend signals
MD66.7%positive activity pressure
RS14.3%positive relative leadership
Four-week leaders
IndustryDK Medical Instruments & Supplies
4-week rank1 / 1
Group average9.1%
Trend breadth0.0%
Trend0.0%active weekly trend signals
MD100.0%positive activity pressure
RS0.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape30/100
Trend, activity pressure, participation, and risk combine to a 30/100 tape read.
Indicator analysis18/100Latest 12-week confirmation: trend 0/12, activity pressure 5/12, relative leadership 0/12.
Activity pressure 0.07; No reversal markers Next-Week ExpectancyNegative 41.94%Next-week expectancy is negative with a 41.94% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 5 relevant articles.
Assessing Coloplast (CPSE:COLO B) Valuation After Titan Prime’s FDA Approval And U.S. Growth Prospects Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 437.5 DKK | 1.9% | 434.1 DKK | 658.5 DKK | 1.15 | -14.88 | 1.1M | Off |
| 31 Jul 2026 | 429.4 DKK | 6.4% | 438.2 DKK | 660.5 DKK | 1.06 | -16.85 | 1.8M | Off |
| 24 Jul 2026 | 403.6 DKK | -4.5% | 441.5 DKK | 662.4 DKK | 0.78 | -22.02 | 1.4M | Off |
| 17 Jul 2026 | 422.8 DKK | 5.4% | 445.9 DKK | 664.7 DKK | 0.54 | -21.94 | 2.0M | Off |
| 10 Jul 2026 | 401.0 DKK | 1.5% | 449.9 DKK | 666.8 DKK | 0.09 | -25.33 | 2.0M | Off |
| 3 Jul 2026 | 394.9 DKK | 3.4% | 455.1 DKK | 668.8 DKK | -0.28 | -27.98 | 337.9K | Off |
| 26 Jun 2026 | 381.9 DKK | 0.8% | 461.0 DKK | 671.0 DKK | -0.49 | -27.28 | 269.6K | Off |
| 19 Jun 2026 | 378.8 DKK | -1.1% | 466.8 DKK | 673.5 DKK | -0.47 | -26.12 | 625.2K | Off |
| 12 Jun 2026 | 382.9 DKK | -0.2% | 472.7 DKK | 676.1 DKK | -0.41 | -27.04 | 302.3K | Off |
| 5 Jun 2026 | 383.7 DKK | -3.1% | 478.7 DKK | 678.7 DKK | -0.64 | -26.85 | 1.5M | Off |
| 29 May 2026 | 395.8 DKK | -1.9% | 485.2 DKK | 681.2 DKK | -0.87 | -26.29 | 2.2M | Off |
| 22 May 2026 | 403.6 DKK | 2.4% | 490.7 DKK | 683.8 DKK | -1.21 | -25.47 | 2.3M | Off |
| 15 May 2026 | 394.3 DKK | -0.8% | 496.7 DKK | 686.3 DKK | -1.54 | -26.98 | 1.1M | Off |
| 8 May 2026 | 397.6 DKK | -0.0% | 502.2 DKK | 689.1 DKK | -1.43 | -26.01 | 1.8M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.